/PRNewswire/ Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion.
/PRNewswire/ The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the.
/PRNewswire/ Sobi plans to publish its report for the fourth quarter and full year of 2023 on 8 February 2024 at 08:00 CET. Investors, analysts, and media.
/PRNewswire/ Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) ("Sobi") has, as previously announced, carried out a share issue of series C shares,.